Invesco Income Advantage International Fund is a registered fund series of AIM Growth Series (Invesco Growth Series) (series S000000473). Net assets $55.7M as of 2024-12-31.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Invesco Treasury Portfolio | — | $7.5M | 1344.78% |
| Invesco Government & Agency Portfolio | — | $4.0M | 724.95% |
| iShares Core MSCI Emerging Markets ETF | — | $2.5M | 447.87% |
| Invesco Private Prime Fund | — | $1.8M | 327.52% |
| Invesco Private Government Fund | — | $701K | 125.70% |
| Royal Bank of Canada | — | $675K | 121.14% |
| Novartis AG | — | $649K | 116.48% |
| Deutsche Telekom AG | — | $581K | 104.30% |
| Novo Nordisk A/S | — | $573K | 102.86% |
| Canadian Imperial Bank of Commerce | — | $570K | 102.20% |
| Roche Holding AG | — | $536K | 96.12% |
| J.P. Morgan Structured Products B.V. | — | $517K | 92.78% |
| Tencent Holdings Ltd. | — | $454K | 81.49% |
| Taiwan Semiconductor Manufacturing Co. Ltd. | — | $413K | 74.05% |
| Nestle S.A. | — | $400K | 71.76% |
| Report date | Net assets |
|---|---|
| 2024-12-31 | $55.7M |
| 2024-09-30 | $60.5M |
| 2024-06-30 | $59.6M |
| 2024-03-31 | $59.4M |
| 2023-12-31 | $59.6M |
| 2023-09-30 | $57.4M |
| 2023-06-30 | $59.5M |
| 2023-03-31 | $59.3M |